BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11122897)

  • 21. Preservation of fertility and the impact of subsequent pregnancy in patients with premenopausal breast cancer.
    Park M; Davidson R; Fox K
    Semin Oncol; 2006 Dec; 33(6):664-71. PubMed ID: 17145346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian function and childbearing issues in breast cancer survivors.
    Gadducci A; Cosio S; Genazzani AR
    Gynecol Endocrinol; 2007 Nov; 23(11):625-31. PubMed ID: 17926162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of menopausal sequelae in patients with breast cancer.
    Rostom AY
    Clin Oncol (R Coll Radiol); 2001; 13(3):174-80. PubMed ID: 11527291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy and fertility.
    Blumenfeld Z
    Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):379-90. PubMed ID: 22281514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer.
    Minton SE; Munster PN
    Cancer Control; 2002; 9(6):466-72. PubMed ID: 12514564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Breast cancer and fertility: critical review, considerations and perspectives].
    This P
    Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotropin-releasing hormone analogue for premenopausal women with breast cancer.
    Loibl S; Gerber B
    JAMA; 2011 Oct; 306(16):1760; author reply 1760-1. PubMed ID: 22028347
    [No Abstract]   [Full Text] [Related]  

  • 29. [Breast cancer and subsequent pregnancy. Infertility, death risk and survival].
    Ramírez-Torres N; Robles-Robles AG; Villafaña-Vázquez VH; Hernández-Valencia M
    Ginecol Obstet Mex; 2010 Feb; 78(2):85-93. PubMed ID: 20939209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity.
    Ben-Aharon I; Meizner I; Granot T; Uri S; Hasky N; Rizel S; Yerushalmi R; Sulkes A; Stemmer SM
    Oncologist; 2012; 17(11):1386-93. PubMed ID: 22956534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintaining fertility in young women with breast cancer.
    Hulvat MC; Jeruss JS
    Curr Treat Options Oncol; 2009 Dec; 10(5-6):308-17. PubMed ID: 20238254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer and fertility preservation: fertility preservation in breast cancer patients.
    Maltaris T; Weigel M; Mueller A; Schmidt M; Seufert R; Fischl F; Koelbl H; Dittrich R
    Breast Cancer Res; 2008; 10(2):206. PubMed ID: 18492214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.
    Partridge AH; Burstein HJ; Winer EP
    J Natl Cancer Inst Monogr; 2001; (30):135-42. PubMed ID: 11773307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer.
    Wolff AC; Davidson NE
    J Clin Oncol; 2006 Nov; 24(31):4949-51. PubMed ID: 17075110
    [No Abstract]   [Full Text] [Related]  

  • 35. The risk of premature menopause induced by chemotherapy for early breast cancer.
    Lower EE; Blau R; Gazder P; Tummala R
    J Womens Health Gend Based Med; 1999 Sep; 8(7):949-54. PubMed ID: 10534297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
    Knobf MT
    Oncologist; 2006 Feb; 11(2):96-110. PubMed ID: 16476831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Retrospective Study on the Onset of Menopause after Chemotherapy: Analysis of Data Extracted from the Jean Perrin Comprehensive Cancer Center Database Concerning 345 Young Breast Cancer Patients Diagnosed between 1994 and 2012.
    Dohou J; Mouret-Reynier MA; Kwiatkowski F; Arbre M; Herviou P; Pouget M; Abrial C; Penault-Llorca F
    Oncology; 2017; 92(5):255-263. PubMed ID: 28171863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comment on: sexual and fertility adverse effects associated with chemotherapy treatment in women.
    Blumenfeld Z
    Expert Opin Drug Saf; 2014 Sep; 13(9):1283-5. PubMed ID: 25105679
    [No Abstract]   [Full Text] [Related]  

  • 39. [Adjuvant chemotherapy for breast cancer and fertility: estimation of the impact, options of preservation and role of the oncologist].
    Mailliez A; Decanter C; Bonneterre J
    Bull Cancer; 2011 Jul; 98(7):741-51. PubMed ID: 21700552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
    Lambertini M; Cinquini M; Moschetti I; Peccatori FA; Anserini P; Valenzano Menada M; Tomirotti M; Del Mastro L
    Eur J Cancer; 2017 Jan; 71():25-33. PubMed ID: 27940355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.